BMPR-II Antibody

Western Blot: BMPR-II Antibody [NBP1-32218]

Western Blot: BMPR-II Antibody [NBP1-32218] - Wild-type (WT) and BMPR2 knockout (KO) HeLa cell extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with BMPR2 antibody diluted at 1:500. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.

Western Blot: BMPR-II Antibody [NBP1-32218]

Western Blot: BMPR-II Antibody [NBP1-32218] - Various whole cell extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with BMPR2 antibody [C1C3] diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.

Western Blot: Rabbit Polyclonal BMPR-II Antibody [NBP1-32218]

Western Blot: Rabbit Polyclonal BMPR-II Antibody [NBP1-32218] - Bone lysate homogenate from goats. SDS-PAGE with 0.3 mg of total protein from the homogenate per well. BMP-2, NBP1-32218, was used at a dilution of 1:1000 and RUNX/CBFA1, NBP2-24755 was used at a dilution of 1:1000 in TBS Tween and 5% powdered milk. The protein was labeled at 150 kDa. Quantification of BMP-2 in bone graft in the tibia of intrailiac cellularized goats at different times compared with tibial autograft and untreated bone defect. Evaluation of pre-cellularized graft in the iliac crest in the treatment of bone defects in the tibia of goats. G1: cellularized graft for 4 weeks applied to the tibial bone defect, G2: cellularized graft for 6 weeks applied to the tibial bone defect, G3: cellularized graft for 8 weeks applied to the tibial bone defect, G4: tibial autograft and G5: untreated bone defect. All groups were evaluated 120 days after graft implantation. Image from a verified customer review.